Clalit Health Services Our direct engagement and ongoing collaboration with Clalit Health Services help ensure that Data2Life’s products serve the needs of the healthcare industry and reflect the market’s leading edge. Clalit has a 360 degree Electronic Health Records coverage of ambulatory and hospital care, with an aggregated data warehouse that received feeds from both, on our 4.5 million members, for almost two decades. This data included detailed and full demographic, diagnoses, lab results, costs per patients, drugs (both prescription and dispensing data) and administrative data. Clalit is the owner of 14 public hospitals and over 1,400 community clinics throughout Israel. In 2010, Clalit launched its Research Institute, which now holds over 18 professionals of multidisciplinary qualifications – top notch clinicians, epidemiologists, biostatisticians, IT experts, algorithm specialists and public health experts. The institute associates gained invaluable experience in mining and interpreting the organizational database and creating tools introduced into policy and medical practice. These tools allowed for implementing innovative clinical interventions to tackle key health issues such as reducing healthcare disparities, preventing avoidable readmissions, tackling inadequate treatment adherence, assessing the impact of multi-morbidity, improving control of key chronic diseases, performing comparative effectiveness real-life studies and using predictive modeling and advanced analytics to allow targeted care in high risk groups. Clalit’s Research Institute has been recently designated by the WHO as one of the 10 Collaborating Centers for chronic diseases research and prevention. Kantar Health We have partnered with Kantar Health, a leading global healthcare consulting firm, to provide early signal intelligence on drug side effects based on “real-world” information to the pharmaceutical industry. Multilayered data combined with machine learning and analysis will give pharmaceutical and biotech companies timely indicators to strengthen pharmacovigilance and risk management, reveal innovation opportunities and optimize clinical trial design. Kantar Health serves as a trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.